Meta Description: Learn about the latest clinical trial on the combination of Traditional Chinese Medicine and Western techniques targeting precocious puberty, sponsored by the Children’s Hospital of Fudan University.
On January 10, 2026, the integration of traditional Chinese medicine (TCM) alongside Western medical approaches took a significant step forward with the announcement of a new clinical trial. Aimed at addressing precocious puberty, this innovative research is sponsored by the Children’s Hospital of Fudan University. Regulatory and clinical teams monitoring pediatric care and hormonal development therapies should take note of this crucial development, as this study explores the safety and performance of TCM formulations in a regulated therapeutic context.
In this article:
- What is the focus of this study?
- What methodology is being implemented?
- Who is this research targeting?
- When is this study expected to progress?
- FAQ
- Conclusion
- Disclaimer
- Study Announcement Link
What is the focus of this study?
The clinical investigation centers on the treatment of precocious puberty, a condition characterized by an unusually early onset of puberty in children. Researchers will examine the effects of Mulberry and Lotus Leaf Heat-Clearing Granules—a Traditional Chinese Medicine (TCM) formula—administered alongside a placebo-controlled regimen. This combined approach evaluates both efficacy and potential integration with current Western standards for addressing this hormonal imbalance among children.
What methodology is being implemented?
The study employs a combination of pharmacological and placebo interventions. The TCM component, dubbed “Mulberry and Lotus Leaf Heat-Clearing Granules,” comprises an evidence-based formula of mulberry leaves, lotus leaves, fresh rehmannia, anemarrhena, scutellaria, and atractylodes. Participants will receive either the active TCM granules or a 10% drug-containing placebo over a carefully monitored three-month administration period.
The research seeks to evaluate the granules’ impact on mitigating hormonal indicators of precocious puberty. Its design adheres to rigorous clinical protocols, ensuring data credibility and patient safety under standardized controls.
Who is this research targeting?
This clinical trial focuses on children experiencing early-onset puberty. The selection criteria aim to identify candidates within defined hormonal, physical, and developmental benchmarks to ensure an accurate assessment of the intervention’s therapeutic efficacy. Parents, pediatric specialists, and hormonal treatment researchers are encouraged to track this trial’s findings for potential integration into broader pediatric practices.
When is this study expected to progress?
The research phase is expected to commence soon; however, recruitment has not yet begun as of this announcement. Stakeholder involvement, including hospital outreach and regulatory submission updates, will significantly influence this timeline. Those interested in scientific and quality contributions should monitor progress through the trial’s official documentation.
FAQ
1. What are Mulberry and Lotus Leaf Heat-Clearing Granules?
This is a Traditional Chinese Medicine formula composed of mulberry leaves, lotus leaves, fresh rehmannia, anemarrhena, scutellaria, and atractylodes, designed to address hormonal imbalances.
2. How long will the trial last?
The proposed clinical trial duration is three months with active monitoring.
3. Where can I find updates on the recruitment status?
Recruitment and trial progress updates will be available through ClinicalTrials.gov. Refer to the link provided in the announcement section.
Conclusion
This study holds promise for advancing the integration of traditional Chinese medicine in managing early-onset puberty. For stakeholders involved in clinical trials, regulatory compliance, or pediatric medicine, this development provides a unique opportunity to explore the intersection of TCM and Western therapeutic approaches. Monitoring its outcomes could enrich treatment portfolios globally.
Disclaimer
This blog post is for informational purposes and does not constitute legal or medical advice. For specific regulatory guidance, consult a qualified professional.
Study Announcement Link
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07325903?term=medical+device